DexCom, Inc. Overview
Pro stress-test →DexCom is a medical device company that sells continuous glucose monitoring (CGM) systems that efficiently manage diabetes and metabolic conditions by tracking glucose levels every few minutes. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years.
Strategic Profile
Pro stress-test →The company designs and commercializes continuous glucose monitoring systems that serve as an alternative to traditional blood glucose meters and is evolving its CGM systems to provide integration with insulin pumps for automatic insulin delivery. Growth is driven by higher sensor volumes, the Stelo rollout (for prediabetes and Type 2 patients), and further international expansion.
Competitive Landscape
Pro stress-test →Intensifying CGM competition presents challenges, particularly in DexCom's core insulin-intensive segment. Major competitors include Senseonics (Eversense system) and Tandem Diabetes Care, which offers competing continuous glucose monitoring solutions. DexCom's CGMs are available through medical equipment distributors and retail pharmacies.
Industry Context
DexCom, Inc. operates in Medical Devices - Continuous Glucose Monitoring (CGM) / Diabetes Management.
Key facts
Founded: 1999 · Headquarters: San Diego, US · Revenue: $4.66B · Market cap: $27.3B